{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:10:32Z","timestamp":1790327432048,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-111072"],"award-info":[{"award-number":["MOP-111072"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-130373"],"award-info":[{"award-number":["MOP-130373"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014055","name":"U.S. Army Medical Research Acquisition Activity","doi-asserted-by":"publisher","award":["W 81XWH-21-1-0426"],"award-info":[{"award-number":["W 81XWH-21-1-0426"]}],"id":[{"id":"10.13039\/100014055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hrthm.2026.06.003","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:24:10Z","timestamp":1780586650000},"page":"e2543-e2554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antisense-mediated gene therapy targeting DMPK restores cardiac ion channel function and electrical stability in myotonic dystrophy type 1"],"prefix":"10.1016","volume":"23","author":[{"given":"Marion","family":"Pierre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Sourisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Jauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Pouliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Carrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paymaan","family":"Jafar-Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Boutjdir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9500-2839","authenticated-orcid":false,"given":"Mohamed","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2026.06.003_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/355545a0","article-title":"Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy","volume":"355","author":"Harley","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.hrthm.2026.06.003_bib2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member","volume":"68","author":"Brook","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.hrthm.2026.06.003_bib3","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1546325","article-title":"Myotonic dystrophy mutation: an unstable CTG repeat in the 3\u2032 untranslated region of the gene","volume":"255","author":"Mahadevan","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.hrthm.2026.06.003_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0092-8674(95)90074-8","article-title":"Trinucleotide repeats that expand in human disease form hairpin structures in vitro","volume":"81","author":"Gacy","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.hrthm.2026.06.003_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S1355838200991544","article-title":"Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR","volume":"6","author":"Tian","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.hrthm.2026.06.003_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.8036515","article-title":"Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene","volume":"265","author":"Wang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.hrthm.2026.06.003_bib7","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1073\/pnas.94.14.7388","article-title":"Expansion of a CUG trinucleotide repeat in the 3\u2032 untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts","volume":"94","author":"Davis","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2026.06.003_bib8","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/hmg\/10.19.2165","article-title":"Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2","volume":"10","author":"Mankodi","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2026.06.003_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1432-0436.2006.00060.x","article-title":"The muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing","volume":"74","author":"Pascual","year":"2006","journal-title":"Differentiation"},{"key":"10.1016\/j.hrthm.2026.06.003_bib10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1101\/gr.184390.114","article-title":"Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins","volume":"25","author":"Wang","year":"2015","journal-title":"Genome Res"},{"key":"10.1016\/j.hrthm.2026.06.003_bib11","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1093\/nar\/27.17.3534","article-title":"Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein","volume":"27","author":"Michalowski","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hrthm.2026.06.003_bib12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/hmg\/ddi162","article-title":"Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy","volume":"14","author":"Ho","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2026.06.003_bib13","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1074\/jbc.M005960200","article-title":"RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1","volume":"276","author":"Timchenko","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2026.06.003_bib14","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","article-title":"Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat","volume":"289","author":"Mankodi","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.hrthm.2026.06.003_bib15","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ng1857","article-title":"Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy","volume":"38","author":"Mahadevan","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.hrthm.2026.06.003_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003043","article-title":"Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus","volume":"8","author":"Huguet","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.hrthm.2026.06.003_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113359","article-title":"Recent progress and challenges in the development of antisense therapies for myotonic dystrophy Type 1","volume":"23","author":"De Serres-B\u00e9rard","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hrthm.2026.06.003_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1474-4422(23)00001-7","article-title":"Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1\/2a trial","volume":"22","author":"Thornton","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103489","article-title":"The myotonic dystrophy type 1 drug development pipeline: 2022 edition","volume":"28","author":"Pascual-Gilabert","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.hrthm.2026.06.003_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/jpet.115.226969","article-title":"Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1","volume":"355","author":"Pandey","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.hrthm.2026.06.003_bib21","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1089\/hum.2022.069","article-title":"Enhanced delivery of ligand-conjugated antisense oligonucleotides (C16-HA-ASO) targeting dystrophia myotonica protein kinase transcripts for the treatment of myotonic dystrophy Type 1","volume":"33","author":"Ait Benichou","year":"2022","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.hrthm.2026.06.003_bib22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41434-022-00316-7","article-title":"Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1","volume":"29","author":"Ait Benichou","year":"2022","journal-title":"Gene Ther"},{"key":"10.1016\/j.hrthm.2026.06.003_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.omtn.2017.05.007","article-title":"Targeting DMPK with antisense oligonucleotide improves muscle strength in myotonic dystrophy Type 1 mice","volume":"7","author":"Jauvin","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.hrthm.2026.06.003_bib24","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/hmg\/ddaa060","article-title":"Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3\u2019UTR RNA","volume":"29","author":"Yadava","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2026.06.003_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2023.103037","article-title":"Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoids cell lines","volume":"67","author":"Jauvin","year":"2023","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.hrthm.2026.06.003_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1258318","article-title":"Cardiac involvement in patient-specific induced pluripotent stem cells of myotonic dystrophy type 1: unveiling the impact of voltage-gated sodium channels","volume":"14","author":"Pierre","year":"2023","journal-title":"Front Physiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib27","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/hmg\/ddw266","article-title":"Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice","volume":"25","author":"Carrell","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2026.06.003_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.acvd.2013.08.003","article-title":"Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1","volume":"106","author":"Wahbi","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.hrthm.2026.06.003_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11067","article-title":"Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy","volume":"7","author":"Freyermuth","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2026.06.003_bib30","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1038\/s41598-021-82007-8","article-title":"iPSC-derived cardiomyocytes from patients with myotonic dystrophy type 1 have abnormal ion channel functions and slower conduction velocities","volume":"11","author":"Poulin","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.hrthm.2026.06.003_bib31","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJMoa062800","article-title":"Electrocardiographic abnormalities and sudden death in myotonic dystrophy Type 1","volume":"358","author":"Groh","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2026.06.003_bib32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.tcm.2019.06.001","article-title":"Cardiovascular manifestations of myotonic dystrophy","volume":"30","author":"Wahbi","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.06.003_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010393","article-title":"CRISPR -mediated expression of the fetal Scn5a isoform in adult mice causes conduction defects and arrhythmias","volume":"7","author":"Pang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2026.06.003_bib34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jcp.21451","article-title":"Alternative splicing of Nav1.5: an electrophysiological comparison of \u2018neonatal\u2019 and \u2018adult\u2019 isoforms and critical involvement of a lysine residue","volume":"216","author":"Onkal","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005135","article-title":"Switch from fetal to adult SCN5A isoform in human induced pluripotent stem cell\u2013derived cardiomyocytes unmasks the cellular phenotype of a conduction disease\u2013causing mutation","volume":"6","author":"Veerman","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2026.06.003_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yjmcc.2009.07.013","article-title":"Molecular determinants of cardiac transient outward potassium current (I(to)) expression and regulation","volume":"48","author":"Niwa","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib37","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.hrthm.2021.04.008","article-title":"Cardiac potassium inward rectifier Kir2: review of structure, regulation, pharmacology, and arrhythmogenesis","volume":"18","author":"Reilly","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.06.003_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.hrthm.2004.11.012","article-title":"The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis","volume":"2","author":"Dhamoon","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.06.003_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262210992","article-title":"Cardiac involvement in myotonic dystrophy Type 1: mechanisms, clinical perspectives, and emerging therapeutic strategies","volume":"26","author":"Ginjupalli","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hrthm.2026.06.003_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1257682","article-title":"Electrophysiological basis of cardiac arrhythmia in a mouse model of myotonic dystrophy type 1","volume":"14","author":"Ginjupalli","year":"2023","journal-title":"Front Physiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib41","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.201912450","article-title":"Biophysical mechanisms for QRS- and QTc-interval prolongation in mice with cardiac expression of expanded CUG-repeat RNA","volume":"152","author":"Tylock","year":"2020","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3988\/jcn.2013.9.3.186","article-title":"Prolonged corrected QT interval in patients with myotonic dystrophy Type 1","volume":"9","author":"Park","year":"2013","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1113\/jphysiol.2006.126714","article-title":"Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart","volume":"582","author":"Gaborit","year":"2007","journal-title":"J Physiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yjmcc.2013.03.014","article-title":"Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes","volume":"60","author":"Cordeiro","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yjmcc.2018.03.012","article-title":"Modelling the pathogenesis of Myotonic Dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytes","volume":"118","author":"Spitalieri","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib46","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.hrthm.2010.09.017","article-title":"Early afterdepolarizations and cardiac arrhythmias","volume":"7","author":"Weiss","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.06.003_bib47","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3389\/fphys.2019.01545","article-title":"Multiple dynamical mechanisms of Phase-2 early afterdepolarizations in a human ventricular myocyte model: involvement of spontaneous SR Ca(2+) release","volume":"10","author":"Kurata","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fphys.2012.00009","article-title":"Experimental Mapping of the Canine KCNJ2 and KCNJ12 Gene Structures and Functional Analysis of the Canine K(IR)2.2 ion Channel","volume":"3","author":"Houtman","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib49","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.311872","article-title":"Cardiac Kir2.1 and NaV1.5 channels traffic together to the sarcolemma to control excitability","volume":"122","author":"Ponce-Balbuena","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2026.06.003_bib50","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3389\/fphys.2017.00903","article-title":"Kir2.1-Nav1.5 channel complexes are differently regulated than Kir2.1 and Nav1.5 channels alone","volume":"8","author":"Utrilla","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib51","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nsmb.2067","article-title":"Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy","volume":"18","author":"Rau","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib52","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1540-8167.2012.02400.x","article-title":"Intracellular calcium dynamics, shortened action potential duration, and late-phase 3 early afterdepolarization in Langendorff-perfused rabbit ventricles","volume":"23","author":"Tang","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.06.003_bib53","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/hmg\/ddr568","article-title":"Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel","volume":"21","author":"Tang","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2026.06.003_bib54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/genes8120344","article-title":"Alternative splicing of L-type CaV1.2 calcium channels: implications in cardiovascular diseases","volume":"8","author":"Hu","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.hrthm.2026.06.003_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107324","article-title":"RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy Type 1","volume":"9","author":"Klinck","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2026.06.003_bib56","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1038\/ncomms3480","article-title":"MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation","volume":"4","author":"Venables","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2026.06.003_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/19336950.2017.1381805","article-title":"Characterization of CaV1.2 exon 33 heterozygous knockout mice and negative correlation between Rbfox1 and CaV1.2 exon 33 expressions in human heart failure","volume":"12","author":"Wang","year":"2018","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.hrthm.2026.06.003_bib58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12933-023-01894-5","article-title":"Dysregulated Rbfox2 produces aberrant splicing of CaV1.2 calcium channel in diabetes-induced cardiac hypertrophy","volume":"22","author":"Li","year":"2023","journal-title":"Cardiovasc Diabetol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126024562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126024562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:38:36Z","timestamp":1790325516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126024562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1547527126024562"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.06.003","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antisense-mediated gene therapy targeting DMPK restores cardiac ion channel function and electrical stability in myotonic dystrophy type 1","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}